SE440654B - Kvartera salter av n,n?723-di(beta-bompropionyl)-n?721, n?722-dispirotripiperazinium - Google Patents

Kvartera salter av n,n?723-di(beta-bompropionyl)-n?721, n?722-dispirotripiperazinium

Info

Publication number
SE440654B
SE440654B SE8106498A SE8106498A SE440654B SE 440654 B SE440654 B SE 440654B SE 8106498 A SE8106498 A SE 8106498A SE 8106498 A SE8106498 A SE 8106498A SE 440654 B SE440654 B SE 440654B
Authority
SE
Sweden
Prior art keywords
compound
compounds
dispirotripiperazinium
sarcoma
water
Prior art date
Application number
SE8106498A
Other languages
English (en)
Swedish (sv)
Other versions
SE8106498L (sv
Inventor
M I Dorokhova
K V Levshina
O Y Tikhonova
A N Zamskaya
S M Minakova
T S Safonova
V A Chernov
Original Assignee
Vni Khim Farmatsevti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vni Khim Farmatsevti filed Critical Vni Khim Farmatsevti
Publication of SE8106498L publication Critical patent/SE8106498L/xx
Publication of SE440654B publication Critical patent/SE440654B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE8106498A 1981-11-03 1981-11-03 Kvartera salter av n,n?723-di(beta-bompropionyl)-n?721, n?722-dispirotripiperazinium SE440654B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813143592 DE3143592A1 (de) 1981-11-03 1981-11-03 Quaternaere n,n(pfeil hoch)3(pfeil hoch)-di(ss-brompropionyl)-n',n(pfeil hoch)2(pfeil hoch)-dispirotripiperaziniumsalze, verfahren zu deren herstellung und arzneimittel mit zytostatischer wirkung

Publications (2)

Publication Number Publication Date
SE8106498L SE8106498L (sv) 1983-05-04
SE440654B true SE440654B (sv) 1985-08-12

Family

ID=6145490

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8106498A SE440654B (sv) 1981-11-03 1981-11-03 Kvartera salter av n,n?723-di(beta-bompropionyl)-n?721, n?722-dispirotripiperazinium
SE8206728A SE430212B (sv) 1981-11-03 1982-11-25 Lekemedelspreparat med antitumorverkan innehallande n,n?723-di(beta-brompropionyl)-n?721,n?722-di-spirotripiperaziniumdiklorid

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8206728A SE430212B (sv) 1981-11-03 1982-11-25 Lekemedelspreparat med antitumorverkan innehallande n,n?723-di(beta-brompropionyl)-n?721,n?722-di-spirotripiperaziniumdiklorid

Country Status (6)

Country Link
US (1) US4481201A (zh)
JP (1) JPS58103390A (zh)
CH (1) CH648560A5 (zh)
DE (1) DE3143592A1 (zh)
FR (1) FR2516085A1 (zh)
SE (2) SE440654B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10350929A1 (de) * 2003-10-31 2005-06-16 Henkel Kgaa Dispirotripiperazinverbindungen zur Adhäsionshemmung von Pilzen
US8685976B2 (en) 2008-06-18 2014-04-01 Kyoto University Cell adhesion promoting agent and method of promoting cell adhesion
WO2011019636A2 (en) * 2009-08-11 2011-02-17 University Of Florida Research Foundation, Inc. Methods and compositions for the treatment of cancers and pathogenic infections

Also Published As

Publication number Publication date
CH648560A5 (de) 1985-03-29
SE430212B (sv) 1983-10-31
JPS645597B2 (zh) 1989-01-31
DE3143592C2 (zh) 1987-02-05
FR2516085B1 (zh) 1984-04-27
FR2516085A1 (fr) 1983-05-13
SE8106498L (sv) 1983-05-04
DE3143592A1 (de) 1983-05-11
US4481201A (en) 1984-11-06
SE8206728L (sv) 1983-05-04
SE8206728D0 (sv) 1982-11-25
JPS58103390A (ja) 1983-06-20

Similar Documents

Publication Publication Date Title
Beisler Isolation, characterization, and properties of a labile hydrolysis product of the antitumor nucleoside, 5-azacytidine
US8609702B2 (en) Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use
US5519155A (en) Platinum complexes
FR2577551A1 (fr) Derives de benzoyl uree, procede pour les preparer, et compositions antitumorales les contenant
EP0586512A1 (en) Use of rapamycin prodrugs as immunosuppressant agents
CA2076555C (en) Pharmaceuticals for the treatment of rejection reactions in organ transplantations
Ross et al. Cycloaliphatic Amino Acids in Cancer Chemotherspy
US20210253603A1 (en) Main group metal complex and its preparation method and use
US4636508A (en) 5-pyrimidinecarboxyamides and treatment of leukemia therewith
SE440654B (sv) Kvartera salter av n,n?723-di(beta-bompropionyl)-n?721, n?722-dispirotripiperazinium
KR100314720B1 (ko) 포스파젠 삼합체에 도입된 백금 착물, 그의 제조방법 및 그를 유효성분으로 하는 항암제
US7820829B2 (en) Bisbenzisoselenazolonyl derivatives having antineoplastic, anti-inflammatory and antithrombotic activities as well as their use
US5621003A (en) Maillard reaction inhibitor
SE436208B (sv) Sett att framstella 5-fluoro-uracilderivat
US7268245B2 (en) Multinuclear platinum compounds
CN111285900B (zh) 基于紫檀芪和香荚兰乙酮的偶联分子dcz0847类化合物、其制备方法及用途
EP0071374A1 (en) Nitrosourea derivatives having anti-tumour and anti-bacterial activity
JP2642134B2 (ja) マイトマイシン誘導体
Warren et al. Quinazolinylformamidines and quinazolinediylbisformamidines as antihypertensive agents
JPH06279287A (ja) 癌転移抑制剤
CN116375789A (zh) 一种抗肿瘤化合物、其制备方法、药物组合物及应用
CN114605450A (zh) 一种含硼苄胍类化合物及其合成与其在制备诊疗一体化药物中的应用
KR810000876B1 (ko) 항암작용제 안트라퀴논 화합물의 제법
JPH01272592A (ja) 新規白金含有化合物および悪性腫瘍治療剤
IsLIP Progress in the Experimental Chemotherapy of Helminth

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8106498-2

Effective date: 19910611

Format of ref document f/p: F